Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dancing | 6 | 2024 | 105 | 1.410 |
Why?
|
Gossypol | 6 | 2015 | 23 | 0.970 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2015 | 1406 | 0.680 |
Why?
|
Athletic Injuries | 6 | 2020 | 1245 | 0.610 |
Why?
|
Adolescent Development | 1 | 2020 | 276 | 0.560 |
Why?
|
Minocycline | 1 | 2015 | 170 | 0.450 |
Why?
|
Hallux | 2 | 2021 | 43 | 0.360 |
Why?
|
Pancreatic Neoplasms | 5 | 2015 | 5442 | 0.360 |
Why?
|
Mental Health | 1 | 2020 | 3275 | 0.260 |
Why?
|
Interleukins | 5 | 2015 | 796 | 0.250 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 426 | 0.250 |
Why?
|
Adenoviridae | 4 | 2015 | 1093 | 0.250 |
Why?
|
Sleep | 1 | 2020 | 4818 | 0.230 |
Why?
|
Gene Silencing | 1 | 2009 | 1505 | 0.210 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1155 | 0.210 |
Why?
|
Sesamoid Bones | 1 | 2021 | 14 | 0.190 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2830 | 0.180 |
Why?
|
Basketball | 1 | 2021 | 45 | 0.180 |
Why?
|
Oncolytic Viruses | 2 | 2015 | 344 | 0.180 |
Why?
|
Gene Transfer Techniques | 3 | 2014 | 1207 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2015 | 3612 | 0.160 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 2956 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 11878 | 0.160 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 180 | 0.160 |
Why?
|
Sports Medicine | 1 | 2021 | 239 | 0.150 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13677 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6395 | 0.140 |
Why?
|
Drug Design | 2 | 2012 | 1046 | 0.140 |
Why?
|
Running | 1 | 2021 | 490 | 0.140 |
Why?
|
Apoptosis | 5 | 2015 | 9527 | 0.130 |
Why?
|
Cell Line, Tumor | 9 | 2015 | 17142 | 0.130 |
Why?
|
Tarsal Joints | 1 | 2015 | 32 | 0.120 |
Why?
|
Ovarian Neoplasms | 2 | 2009 | 4916 | 0.120 |
Why?
|
Receptor, EphA2 | 1 | 2015 | 41 | 0.120 |
Why?
|
Nitrophenols | 1 | 2015 | 169 | 0.120 |
Why?
|
Tarsal Bones | 1 | 2015 | 72 | 0.120 |
Why?
|
Range of Motion, Articular | 2 | 2019 | 1597 | 0.120 |
Why?
|
Tetracycline | 1 | 2015 | 216 | 0.120 |
Why?
|
Ankle Joint | 1 | 2019 | 452 | 0.120 |
Why?
|
Muscle Strength | 1 | 2019 | 640 | 0.120 |
Why?
|
Poly I-C | 1 | 2014 | 111 | 0.120 |
Why?
|
Drug Synergism | 2 | 2015 | 1760 | 0.110 |
Why?
|
Foot Injuries | 1 | 2015 | 154 | 0.110 |
Why?
|
Mice, Nude | 6 | 2015 | 3623 | 0.110 |
Why?
|
Post-Concussion Syndrome | 1 | 2016 | 257 | 0.100 |
Why?
|
Oncolytic Virotherapy | 2 | 2015 | 520 | 0.100 |
Why?
|
Syntenins | 1 | 2012 | 8 | 0.100 |
Why?
|
Hip Joint | 1 | 2019 | 1018 | 0.100 |
Why?
|
Neoplasms | 4 | 2012 | 22371 | 0.090 |
Why?
|
Knee Joint | 1 | 2019 | 1683 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 719 | 0.090 |
Why?
|
Biphenyl Compounds | 1 | 2015 | 1026 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2015 | 597 | 0.090 |
Why?
|
Receptors, Virus | 1 | 2012 | 651 | 0.080 |
Why?
|
Animals | 14 | 2015 | 169285 | 0.070 |
Why?
|
Paclitaxel | 1 | 2015 | 1733 | 0.070 |
Why?
|
Integrases | 1 | 2009 | 520 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 2015 | 11101 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4528 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8542 | 0.060 |
Why?
|
Motor Activity | 1 | 2016 | 2711 | 0.060 |
Why?
|
Genomic Instability | 1 | 2009 | 716 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1982 | 0.060 |
Why?
|
Interleukin-10 | 1 | 2010 | 1184 | 0.060 |
Why?
|
Humans | 26 | 2024 | 768171 | 0.060 |
Why?
|
Adolescent | 6 | 2024 | 89169 | 0.060 |
Why?
|
Mice | 8 | 2015 | 82049 | 0.050 |
Why?
|
Athletes | 2 | 2021 | 1162 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1756 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13490 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5151 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8648 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2007 | 936 | 0.050 |
Why?
|
Cell Membrane | 1 | 2009 | 3655 | 0.040 |
Why?
|
Hip Injuries | 1 | 2020 | 79 | 0.040 |
Why?
|
Weight Lifting | 1 | 2020 | 130 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4058 | 0.040 |
Why?
|
Specialization | 1 | 2024 | 779 | 0.040 |
Why?
|
Alleles | 1 | 2009 | 6894 | 0.040 |
Why?
|
Joints | 1 | 2020 | 324 | 0.040 |
Why?
|
Pelvic Bones | 1 | 2020 | 274 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2009 | 3703 | 0.040 |
Why?
|
Spinal Injuries | 1 | 2020 | 300 | 0.030 |
Why?
|
Female | 12 | 2024 | 397187 | 0.030 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2015 | 17 | 0.030 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2015 | 39 | 0.030 |
Why?
|
Child | 5 | 2024 | 80917 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5756 | 0.030 |
Why?
|
Knee Injuries | 1 | 2020 | 495 | 0.030 |
Why?
|
Protein Modification, Translational | 1 | 2014 | 21 | 0.030 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2015 | 85 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 5789 | 0.030 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 61 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2015 | 412 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2237 | 0.030 |
Why?
|
Serotyping | 1 | 2014 | 331 | 0.030 |
Why?
|
Male | 11 | 2021 | 364731 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2015 | 319 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5706 | 0.030 |
Why?
|
RNA, Double-Stranded | 1 | 2014 | 292 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5797 | 0.030 |
Why?
|
Chemoprevention | 1 | 2014 | 327 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6975 | 0.020 |
Why?
|
Syndecans | 1 | 2012 | 75 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2015 | 559 | 0.020 |
Why?
|
Gelatinases | 1 | 2012 | 93 | 0.020 |
Why?
|
Quinolones | 1 | 2015 | 389 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2012 | 166 | 0.020 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2012 | 120 | 0.020 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 147 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2015 | 13422 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2395 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1074 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1151 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1505 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 998 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 450 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2015 | 9561 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1906 | 0.020 |
Why?
|
Rats | 2 | 2015 | 23782 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2122 | 0.020 |
Why?
|
Transgenes | 1 | 2012 | 1016 | 0.020 |
Why?
|
Fracture Fixation, Internal | 1 | 2015 | 982 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 544 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18349 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 60066 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2012 | 1230 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 942 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 256 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2152 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2832 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6231 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 915 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10632 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 306 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2494 | 0.020 |
Why?
|
Receptors, Peptide | 1 | 2007 | 280 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1110 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2211 | 0.020 |
Why?
|
Piperazines | 1 | 2015 | 2554 | 0.010 |
Why?
|
Self Report | 1 | 2016 | 3773 | 0.010 |
Why?
|
Gadolinium DTPA | 1 | 2007 | 823 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6512 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40220 | 0.010 |
Why?
|
Adult | 4 | 2020 | 223646 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18415 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2747 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26379 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10763 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13053 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2810 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 81760 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 36741 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15869 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7876 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74944 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17623 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5341 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39354 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 65379 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9497 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54924 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41753 | 0.010 |
Why?
|
United States | 1 | 2020 | 73039 | 0.010 |
Why?
|
Disease Progression | 1 | 2007 | 13668 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22380 | 0.000 |
Why?
|
Signal Transduction | 1 | 2012 | 23648 | 0.000 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_